Thesis
Biomarkers of anti-angiogenic therapy in breast cancer
- Abstract:
-
The hunt for biomarkers for anti-VEGF agent bevacizumab is ongoing since last decade with no success. Identifying robust biomarkers for stratifying patients and for monitoring response is important for the future use of bevacizumab in breast cancer. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) analysis and genome wide gene expression analysis are two promising approaches to understand the molecular mechanisms and search for biomarker of anti-angiogenic therapy. Firstly, w...
Expand abstract
Actions
Bibliographic Details
- Publication date:
- 2014
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- University of Oxford
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:8b3869e3-fd60-450c-b165-0fe773681613
- Local pid:
- ora:10132
- Deposit date:
- 2015-02-19
Terms of use
- Copyright holder:
- Mehta, S
- Copyright date:
- 2014
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record